Form 8-K - Current report:
SEC Accession No. 0001213900-14-005484
Filing Date
2014-08-07
Accepted
2014-08-07 16:27:26
Documents
2
Period of Report
2014-08-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k080614_relmada.htm 8-K 15690
2 PRESS RELEASE f8k080614ex99i_relmada.htm EX-99.1 11455
  Complete submission text file 0001213900-14-005484.txt   28332
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 333-184881 | Film No.: 141024280
SIC: 3949 Sporting & Athletic Goods, NEC